A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate

被引:38
作者
Chen, M. [1 ]
Chang, J. S. [2 ]
Nason, M. [3 ]
Rangel, D. [4 ]
Gall, J. G. [4 ]
Graham, B. S. [1 ]
Ledgerwood, J. E. [1 ]
机构
[1] NIAID, Viral Pathogenesis Lab, Vaccine Res Ctr, NIH,US Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[2] Kaohsiung Med Univ, Dept Renal Care, Coll Med, Kaohsiung 807, Taiwan
[3] NIAID, Biostat Res Branch, Div Clin Res, NIH,US Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[4] GenVec Inc, Gaithersburg, MD 20878 USA
关键词
RSV; Neutralizing antibody; Reporter virus; RESPIRATORY SYNCYTIAL VIRUS; HEALTHY-ADULTS; CLINICAL-TRIAL; INFECTION; CELLS;
D O I
10.1016/j.jim.2010.08.005
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Respiratory syncytial virus (RSV) is an important cause of respiratory infection in people of all ages, and is the leading cause of hospitalization in infants. Although commercially available monoclonal antibody is available for passive prophylaxis of neonates at risk of severe disease, there is no available vaccine to prevent RSV. Measurement of neutralizing activity will be a key endpoint for vaccine evaluation. Assessment of neutralizing antibody against RSV has been limited to traditional plaque reduction, which is time-consuming and inherently operator dependent and highly variable. Here, we describe a flow cytometry-based RSV-specific neutralization assay which is more rapid than traditional methods, highly sensitive and highly reproducible. Published by Elsevier B.V.
引用
收藏
页码:180 / 184
页数:5
相关论文
共 13 条
[1]   MICRONEUTRALIZATION TEST FOR RESPIRATORY SYNCYTIAL VIRUS BASED ON AN ENZYME-IMMUNOASSAY [J].
ANDERSON, LJ ;
HIERHOLZER, JC ;
BINGHAM, PG ;
STONE, YO .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (06) :1050-1052
[2]  
Andrewes CH, 1933, BRIT J EXP PATHOL, V14, P367
[3]   Viral and host factors in human respiratory syncytial virus pathogenesis [J].
Collins, Peter L. ;
Graham, Barney S. .
JOURNAL OF VIROLOGY, 2008, 82 (05) :2040-2055
[4]   RISK OF RESPIRATORY SYNCYTIAL VIRUS-INFECTION FOR INFANTS FROM LOW-INCOME FAMILIES IN RELATIONSHIP TO AGE, SEX, ETHNIC-GROUP, AND MATERNAL ANTIBODY LEVEL [J].
GLEZEN, WP ;
PAREDES, A ;
ALLISON, JE ;
TABER, LH ;
FRANK, AL .
JOURNAL OF PEDIATRICS, 1981, 98 (05) :708-715
[5]   PRIMARY RESPIRATORY SYNCYTIAL VIRUS-INFECTION IN MICE [J].
GRAHAM, BS ;
PERKINS, MD ;
WRIGHT, PF ;
KARZON, DT .
JOURNAL OF MEDICAL VIROLOGY, 1988, 26 (02) :153-162
[6]   Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection [J].
Hallak, LK ;
Collins, PL ;
Knudson, W ;
Peeples, ME .
VIROLOGY, 2000, 271 (02) :264-275
[7]   Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus [J].
Johnson, S ;
Oliver, C ;
Prince, GA ;
Hemming, VG ;
Pfarr, DS ;
Wang, SC ;
Dormitzer, M ;
OGrady, J ;
Koenig, S ;
Tamura, JK ;
Woods, R ;
Bansal, G ;
Couchenour, D ;
Tsao, E ;
Hall, WC ;
Young, JF .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (05) :1215-1224
[8]  
Klasse PJ, 2001, CURR TOP MICROBIOL, V260, P87
[9]   A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial [J].
Martin, Julie E. ;
Pierson, Theodore C. ;
Hubka, Sarah ;
Rucker, Steve ;
Gordon, Ingelise J. ;
Enama, Mary E. ;
Andrews, Charla A. ;
Xu, Qing ;
Davis, Brent S. ;
Nason, Martha C. ;
Fay, Michael P. ;
Koup, Richard A. ;
Roederer, Mario ;
Bailer, Robert T. ;
Gomez, Phillip L. ;
Mascola, John R. ;
Chang, Gwong-Jen J. ;
Nabel, Gary J. ;
Graham, Barney S. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (12) :1732-1740
[10]   A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial [J].
Martin, Julie E. ;
Louder, Mark K. ;
Holman, LaSonji A. ;
Gordon, Ingelise J. ;
Enama, Mary E. ;
Larkin, Brenda D. ;
Andrews, Charla A. ;
Vogel, Leatrice ;
Koup, Richard A. ;
Roederer, Mario ;
Bailer, Robert T. ;
Gomez, Phillip L. ;
Nason, Martha ;
Mascola, John R. ;
Nabel, Gary J. ;
Graham, Barney S. .
VACCINE, 2008, 26 (50) :6338-6343